October 17, 2007

DNA Software Exhibits Its Expanding Technology Portfolio at the 2007 MichBio Expo.

Ann Arbor, Mich. – October 17, 2007 – DNA Software, Inc. exhibited its science and software developments and growing products and services portfolio at the annual MichBio Expo in Lansing, MI.

DNA Software received The Michigan Investment and Commercialization Success Award in 2003. DNA Software is among the select-few, award-winning, start-up companies that successfully commercialized its technology, continues to expand its R&D and commercial offerings, and is working toward diversifying and growing Michigan’s struggling economy.

DNA Software continues to explore opportunities to develop the biotech industry within Michigan. The company networks with local business-accelerator organizations such as the Michigan Economic Development Corporation (MEDC), MichBio, SPARK, and BioArbor. DNA Software has collaborated with, licensed technology from, licensed software to, and provided consulting services to Michigan universities. When Pfizer Inc decided to close its Ann Arbor R&D facility in early 2007, DNA Software attracted, hired, and retained local talent. Moreover, DNA Software has consulting relationships with former Pfizer scientists and continues to seek expertise in the areas of computational chemistry, structural biology, and mathematical modeling. Interested scientists are encouraged to contact DNA Software.

About DNA Software, Inc.
DNA Software is the leading provider of innovative software and consulting solutions for nucleic acid research. DNA Software combines award-winning science with cutting-edge software technology and offers the industry’s most comprehensive, automated, and predictive software for designing accurate DNA and RNA hybridization assays and reducing costly false positives and negatives.

Not finding what you’re looking for? Let us help. Click or Call +1.734.222.9080

Our Latest

Thursday, 06 November 2014 22:15

DNA Software introduced the full commercial release of ThermoBLAST Cloud Edition (TB-CE). TB-CE provides a new standard for evaluating the target specificity of oligonucleotides.  Click here to learn more.  

read moreView All News & Events
“We find it [Visual OMP™] makes very accurate and sometimes surprising (but true) predictions about binding efficiency in multiplexes...” David Whitcombe, Chief Scientific Officer, DxS Ltd, UK.
“It [Visual OMP™] is very powerful software when used for multiplexing design...” Chris Novak, Ambion
“I have designed over 10,000 PCR assays in my experience with DNA Software’s Visual OMP™ and found greater than 95% success rate when using it to design my assays compared to less than 20% success without it.” Dr. Eric Bruening, MolecularMD
“I have been using DNA [Software™] for a long time, at least 8 years. I want to have the best tools available and that is why we use it.” Dr. Nancy Schoenbrunner, Roche Molecular Systems
“I am a long-term user of Visual OMP™. I like this program very much because it provides a solid scientific basis for oligo design and cuts the development time by more than half.” Olga Budker, longtime Visual OMP user
“In my experience, DNA Software™ saved me 75% of my oligo costs.” Helen Minnis, Wave 80
“DNA [Software™] has passed my tests. I’ve recommended it [Visual OMP™]. It performs extremely well.” Dr. Ned Sekinger, Luminex Corporation
“Learning to use the program [Visual OMP™] is time well spent, and the support staff at DNA Software is always ready and able to help” Dr. Sue J. Kohlhepp, Providence Portland Medical Center.